A comparison of aztreonam/metronidazole and cefotaxime/metronidazole in elective colorectal surgery: Antimicrobial prophylaxis must include gram-positive cover

D. L. Morris*, S. Rodgers Wilson, J. Pain, K. F. Edwardson, J. Jones, C. Strachan, R. Slack

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    20 Citations (Scopus)

    Abstract

    Aztreonam/metronidazole and cefotaxime/metronidazole were compared in a prospective trial in 154 patients undergoing elective colorectal surgery. Three antibiotic doses were given over 16 hours. A significant excess of wound sepsis in the aztreonam group was seen (23/71 vs 9/70 ξ2 6·60; P < 0.01). Sepsis was almost invariably due to Gram-positive organisms and, in particular, Staphylococcus aureus.

    Original languageEnglish
    Pages (from-to)673-678
    Number of pages6
    JournalJournal of Antimicrobial Chemotherapy
    Volume25
    Issue number4
    DOIs
    Publication statusPublished - Apr 1990

    Fingerprint

    Dive into the research topics of 'A comparison of aztreonam/metronidazole and cefotaxime/metronidazole in elective colorectal surgery: Antimicrobial prophylaxis must include gram-positive cover'. Together they form a unique fingerprint.

    Cite this